Les médicaments marqués en jaune ont la description texte.
- ABEVMY /solution/: bevacizumab (400)
- ABEVMY /solution/: bevacizumab (100)
- ADCETRIS /poudre pour solution/: brentuximab vedotin (50)
- AVASTIN /solution/: bevacizumab (25)
- AYBINTIO /solution/: bevacizumab (400)
- AYBINTIO /solution/: bevacizumab (100)
- BAMBEVI /solution/: bevacizumab (100)
- BAMBEVI /solution/: bevacizumab (400)
- BAVENCIO /solution/: avelumab (20)
- BESPONSA /poudre pour solution/: inotuzumab ozogamicin (0.9)
- BLINCYTO /poudre pour solution/: blinatumomab (38.5)
- COLUMVI /solution/: glofitamab (10)
- COLUMVI /solution/: glofitamab (2.5)
- CYRAMZA /solution/: ramucirumab (10)
- DARZALEX /solution/: daratumumab (100)
- DARZALEX /solution/: daratumumab (400)
- DARZALEX SC /solution/: daratumumab (1800)
- ELREXFIO /solution/: elranatamab (44)
- ELREXFIO /solution/: elranatamab (76)
- ENHERTU /poudre pour solution/: trastuzumab deruxtecan (100)
- EPKINLY /solution/: epcoritamab (60)
- EPKINLY /solution/: epcoritamab (5)
- ERBITUX /solution/: cetuximab (2)
- GAZYVA /solution/: obinutuzumab (25)
- HERCEPTIN /poudre pour solution/: trastuzumab (440)
- HERCEPTIN SC /solution/: trastuzumab (600)
- HERZUMA /trousse, poudre pour solution/: trastuzumab (440)
- HERZUMA /poudre pour solution/: trastuzumab (150)
- IMFINZI /solution/: durvalumab (50)
- JEMPERLI /solution/: dostarlimab (50)
- KADCYLA /poudre pour solution/: trastuzumab emtansine (100)
- KADCYLA /poudre pour solution/: trastuzumab emtansine (160)
- KANJINTI /poudre pour solution/: trastuzumab (150)
- KANJINTI /trousse, poudre pour solution/: trastuzumab (420)
- KEYTRUDA /solution/: pembrolizumab (25)
- LIBTAYO /solution/: cemiplimab (350)
- MINJUVI /poudre pour solution/: tafasitamab (200)
- MVASI /solution/: bevacizumab (25)
- MVASI /solution/: bevacizumab (25)
- MYLOTARG /poudre pour solution/: gemtuzumab ozogamicin (4.5)
- OGIVRI /poudre pour solution/: trastuzumab (150)
- OGIVRI /poudre pour solution/: trastuzumab (440), water (20)
- ONTRUZANT /poudre pour solution/: trastuzumab (150)
- ONTRUZANT /poudre pour solution/: trastuzumab (440)
- OPDIVO /solution/: nivolumab (10)
- OPDIVO /solution/: nivolumab (10)
- OPDUALAG /solution/: nivolumab (240), relatlimab (80)
- PADCEV /poudre pour solution/: enfortumab vedotin (20)
- PADCEV /poudre pour solution/: enfortumab vedotin (30)
- PERJETA /solution/: pertuzumab (420)
- PERJETA-HERCEPTIN /solution, trousse, poudre pour solution/: pertuzumab (420), trastuzumab (440)
- PHESGO /solution/: trastuzumab (40), pertuzumab (80)
- PHESGO /solution/: trastuzumab (60), pertuzumab (60)
- POLIVY /poudre pour solution/: polatuzumab vedotin (30)
- POLIVY /poudre pour solution/: polatuzumab vedotin (140)
- RITUXAN /solution/: rituximab (10)
- RITUXAN SC /solution/: rituximab (1400)
- RITUXAN SC /solution/: rituximab (1600)
- RIXIMYO /solution/: rituximab (10)
- RUXIENCE /solution/: rituximab (10)
- RYBREVANT /solution/: amivantamab (350)
- SARCLISA /solution/: isatuximab (100)
- SARCLISA /solution/: isatuximab (500)
- TECENTRIQ /solution/: atezolizumab (1200)
- TECENTRIQ /solution/: atezolizumab (840)
- TECVAYLI /solution/: teclistamab (30)
- TECVAYLI /solution/: teclistamab (153)
- TRAZIMERA /poudre pour solution/: trastuzumab (440)
- TRAZIMERA /poudre pour solution/: trastuzumab (150)
- TRODELVY /poudre pour solution/: sacituzumab govitecan (180)
- TRUXIMA /solution/: rituximab (100)
- TRUXIMA /solution/: rituximab (500)
- UNITUXIN /solution/: dinutuximab (3.5)
- VECTIBIX /solution/: panitumumab (100)
- VECTIBIX /solution/: panitumumab (400)
- VEGZELMA /solution/: bevacizumab (100)
- VEGZELMA /solution/: bevacizumab (400)
- YERVOY /solution/: ipilimumab (5)
- ZIRABEV /solution/: bevacizumab (100)
- ZIRABEV /solution/: bevacizumab (400)
80 médicaments correspondent à la recherche.